ep crush consensu algn ep
handili beat forecast stronger revenu profit
factor line ad ep estim move
latest upsid faster
revenu growth assumpt balanc year beyond tp
move meaning higher view enhanc
convict sustain torrid growth trajectori
heroic top-line momentum profit nice ahead revenu growth
well ahead forecast increas ww
asp vs estimate continu strength total case ship
vs estimate acceler elus teen segment
well plan bp higher revenu fx flow
million fund million capit expenditur
remain debt free million cash reserv
momentum continu acknowledg algn share ralli
recent low april vs view momentum
continu latest unmitig beat encourag
sustain impress double-digit growth trajectori abat
nt guidanc call case shipment growth
low-to-mid revenu growth full year ahead lt target
rang despit increment invest support coloss
growth nt forecast ep growth fastest across hc
 dist coverag univers ev/ebitda share trade
premium dental implant leader straumann view
warrant reflect rapid growth profil risk includ competit
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
manufactur system clear align
therapi intra-or scanner cad/cam digit servic use
dentistri orthodont dental record storag
price jul rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
overal thesi remain improv clinic awar consum sentiment
new technolog enhanc expand geograph teen market focu
drive sustain double-digit revenu growth improv profit thereon
albeit time scalabl cost base outstand debt enhanc
visibl long-term double-digit ep growth encourag algn
commit grow address market via innov drive greater
enthusiasm share higher
continu churn impress quarter strength across nearli everi line
item offer evid algn abil sustain double-digit growth trajectori
continu prevail even aggress growth forecast also make
consider stride across under-penetrated teen market help increasingli
target advertis effort teen case start strong y/i
heel y/i growth seventh consecut quarter teen volum
grew faster adult
estim million orthodont case start year algn clear align
solut invisalign treat case recent juli launch invisalign
first phase clear align design younger patient age earli mix
dentit mixtur primary/perman teeth expand compani reach
though launch recent alreadi note posit respons top
invisalign doctor compani path reach case first month
alon moreov expect expand market reach launch
mandibular advanc product current pend fda approv us
figur clear align case shipment patient type volum
train impress new invisalign doctor vs
includ north latin america help sustain
case growth momentum date boast doctor train world-wide y/i
figur doctor train geograph segment
remain key sourc growth ou clear align revenu rise
repres algn case shipment major
doctor-add also outsid north america note
continu realiz higher averag sell price oversea vs
world-wide averag intern inher key growth area focu
continu highlight strength china primari driver torrid
growth apac compani also note first itero scanner shipment china
quarter well announc regulatori approv manufactur itero
element new manufactur facil china investor day may
highlight china strategi note compani doubl busi
countri year sinc enter market implement deep local
strategi hope drive china top contribut market per lt
apac goal may establish treatment plan center chengdu
moreov also plan launch first manufactur facil apac
region ziyang china plan manufactur clear align
itero scanner see investor day note detail
unveil quarterli ep guidanc slightli lower consensu
midpoint predic revenu growth rel line
consensu like conservat work also note expect revenu
growth low- rang well lt target
importantli see margin pressur similar experi driven
start-up cost relat new china facil among invest
compani expect cost normal volum grow thereon ttm dso improv
modestli sequenti day day expect continu
improv come quarter
acknowledg competitor clearli wing remain well ahead
term innov evidenc recent new product announc invisalign first
next gen itero invisalign go mild-to-moder case expand
address market term competit manag seen chang
marketplac sinc henri schein outperform dentspli sirona
outperform unrat launch new clear aling offer digit
softwar compon annual american associ orthodontist
confer washington dc may
forecast revenu grow billion increas case
shipment ebitda margin expand bp y/i continu invest
go-to-market strategi off-set lower sg overal ep rise
y/i well major hct peer
forecast revenu rise billion driven increas
case shipment estim ebitda margin expand bp yoy ep
increas ev/ebitda share close
premium lead dental implant manufactur straumann view
warrant light algn continu abil exceed high expect excel
innov increasingli effect market strategi
compani mention price
